This article was written by Follow Monte Independent Investment Research: Michael Del Monte is a buy-side equity analyst with over 5 years of industry...
Introduction According to the 2022 10K, ExlService Holdings (NASDAQ:EXLS), is a leading data analytics and digital operations and solutions company that partners with clients...
Lucid Group (NASDAQ:LCID) is full of risks. In times of uncertain macroeconomic conditions and a high-interest rate environment, the company is immensely unprofitable. In...
Introduction Reneo Pharmaceuticals (NASDAQ:RPHM) is a clinical-stage company developing therapies for rare genetic mitochondrial diseases, characterized by impaired mitochondrial ATP production. The company’s primary...
Introduction Puma Biotechnology (NASDAQ:PBYI) is a biopharmaceutical firm focused on enhancing cancer care through innovative solutions. The company is recognized for the commercialization of...